Activist investor Elliott push spurs changes at Medtronic

Key Concepts:

• Activist Investing
• Elliott Management
• Medtronic (MDT)
• Independent Directors
• Revenue Growth
• Earnings Per Share (EPS) Growth
• Margin Improvement
• Supply Chain Management
• Proxy Window
• Accountability
• Operating and Growth Committee

Elliott Management's Activism at Medtronic

Elliott Management, a prominent activist investor, has taken a significant position in Medtronic (MDT) and is pushing for changes to improve the company's performance. This is a relatively recent position for Elliott, established within the last quarter. They are now one of the largest investors in Medtronic.

Board Changes and Independent Directors

As a result of Elliott's involvement, Medtronic has appointed two new independent directors to its board. These directors bring significant experience, including one having run Stryker. While not directly appointed by Elliott, it's implied they are endorsed by the firm. The expectation is that these independent directors will hold management accountable for delivering on growth and margin improvement.

Investor Frustration and Underperformance

Investors have been frustrated with Medtronic's performance over the past decade. While there have been periods of revenue growth, earnings per share (EPS) growth and margin improvement have lagged. The company's navigation of supply chain challenges, particularly during and after the COVID-19 pandemic, has also been a source of disappointment.

Elliott's Expectations and Accountability

Elliott believes Medtronic is at an inflection point and expects the company to deliver on growth and margin improvement. The firm's involvement is aimed at ensuring management is held accountable for executing on these goals.

Proxy Window and Potential for a Vote

Medtronic is not on a fiscal year, meaning the proxy window will open soon. Elliott is known for being willing to go to a vote if necessary to achieve its objectives, as demonstrated in the Phillips 66 case where they successfully placed two directors on the board.

Elliott's Track Record of Activism

Elliott has a history of activist investing in large companies, including Southwest, Phillips 66, Texas Instruments, and Honeywell. Mark Steinberg, a senior figure in Elliott's activism business, is currently on the board of Honeywell.

Medtronic's Operating and Growth Committee

Medtronic has established a new committee focused on operating and growth. This committee is intended to provide further accountability for delivering on execution and achieving the company's growth targets.

Conclusion

Elliott Management's activist involvement in Medtronic is aimed at driving improved performance and holding management accountable. The appointment of new independent directors and the establishment of an operating and growth committee are steps in this direction. The upcoming proxy window will be a key period to watch, as Elliott has demonstrated a willingness to go to a vote if necessary to achieve its goals. The success of this campaign hinges on Medtronic's ability to execute on its growth strategy and improve margins.